Table 1 Demographic, clinical, and laboratory findings of patients with COVID-19 on hospital admission, divided for groups (DSG vs. NDSG)
DSG (N = 62) | NDSG (N = 433) | Overall (N = 495) | p value | |
|---|---|---|---|---|
Sex | 0.031 | |||
Male, n (%) | 23 (37.1) | 224 (51.7) | 247 (49.9) | |
Female, n (%) | 39 (62.9) | 209 (48.3) | 248 (50.1) | |
Age, years ± SD | 70 ± 17 | 72 ± 17 | 72 ± 17 | 0.042 |
CCI, points | 2 (0–4) | 1 (0–3) | 1 (0–3) | 0.046 |
White Blood Cells, n/mmc | 6040 (5130–9450) | 6610 (4935–9585) | 6540 (5020–9670) | 0.75 |
Lymphocytes, n/mmc | 1085 (785–1485) | 1010 (700–1420) | 1015 (710–1463) | 0.24 |
CRP, mg/dl | 6.6 (2.1–13.2) | 5.6 (1.8–11.6) | 5.6 (1.9–11.8) | 0.31 |
Procalcitonin, ng/ml | 0.22 (0.06–0.43) | 0.20 (0.07–0.64) | 0.20 (0.07–0.62) | 0.98 |
Creatinine, mg/dl | 0.94 (0.77–1.42) | 0.97 (0.74–1.28) | 0.96 (0.75–1.29) | 0.60 |
Isoamylase, U/L | 30 (19–54) | 32 (21–51) | 32 (21–52) | 0.92 |
ALT, U/L | 19 (14–34) | 23 (14–37) | 22 (14–36) | 0.51 |
LDH, mg/dl | 282 (202–410) | 268 (199–363) | 269 (200–368) | 0.31 |
CPK, U/L | 86 (48–181) | 95 (46–179) | 89 (46–178) | 0.73 |